Literature DB >> 25349945

Incidence and outcomes of pregnancy-associated melanoma in New South Wales 1994-2008.

Melanie Bannister-Tyrrell1, Christine L Roberts, Csilla Hasovits, Tanya Nippita, Jane B Ford.   

Abstract

BACKGROUND: There is controversy about the interaction between melanoma and pregnancy. There is a lack of Australian data on pregnancy outcomes associated with melanoma in pregnancy, despite Australia having the highest incidence of melanoma in the world. AIMS: Describe trends, maternal characteristics and pregnancy outcomes associated with pregnancy-associated melanoma in New South Wales.
MATERIALS AND METHODS: Population-based cohort study of all births (n = 1 309 501) of at least 20-week gestation or 400 g birthweight in New South Wales, 1994-2008. Logistic regression was used to analyse the association between melanoma in pregnancy and adverse birth outcomes.
RESULTS: 577 pregnancy-associated melanomas were identified, including 195 diagnosed during pregnancy and 382 diagnosed within 12 months postpartum. The crude incidence of pregnancy-associated melanoma increased from 37.1 per 100 000 maternities in 1994 to 51.84 per 100 000 maternities in 2008. Adjusting for maternal age accounted for the trend in pregnancy-associated melanoma. Melanomas diagnosed in pregnancy were thicker (median = 0.75 mm) than melanomas diagnosed postpartum (median = 0.60 mm) (P = 0.002). Pregnancy-associated melanoma was associated with the increased risk of large-for-gestational-age infant but not preterm birth, planned birth, caesarean section or stillbirth. Parity was inversely associated with pregnancy-associated melanoma, as women with three or more previous pregnancies had 0.59 times the odds of pregnancy-associated melanoma compared to nulliparous women (95% CI 0.42-0.84, P = 0.003).
CONCLUSIONS: The incidence of pregnancy-associated melanoma has increased with increasing maternal age. The observation of thicker melanomas in pregnancy and increased risk of large-for-gestational-age infants may suggest a role for growth-related pregnancy factors in pregnancy-associated melanoma.
© 2014 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Keywords:  data linkage; large for gestational age; melanoma; population-based cohort; pregnancy outcomes

Mesh:

Year:  2014        PMID: 25349945     DOI: 10.1111/ajo.12279

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  7 in total

1.  Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival.

Authors:  Bo Li; Yanru Wang; Yinghui Xu; Hongliang Liu; Wendy Bloomer; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Xin Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-01-17       Impact factor: 7.396

2.  Is Pregnancy-Associated Melanoma Associated with Adverse Outcomes?

Authors:  Maris S Jones; Jihey Lee; Stacey L Stern; Mark B Faries
Journal:  J Am Coll Surg       Date:  2017-04-27       Impact factor: 6.113

3.  ZIP9 Is a Druggable Determinant of Sex Differences in Melanoma.

Authors:  Cristina Aguirre-Portolés; Riley Payne; Aspen Trautz; J Kevin Foskett; Christopher A Natale; John T Seykora; Todd W Ridky
Journal:  Cancer Res       Date:  2021-10-27       Impact factor: 12.701

Review 4.  Melanoma in pregnancy.

Authors:  Rebecca Still; Shaun Brennecke
Journal:  Obstet Med       Date:  2017-03-20

5.  Gender-specific associations between polymorphisms of the circadian gene RORA and cutaneous melanoma susceptibility.

Authors:  Clara Benna; Senthilkumar Rajendran; Giovanna Spiro; Chiara Menin; Luigi Dall'Olmo; Carlo Riccardo Rossi; Simone Mocellin
Journal:  J Transl Med       Date:  2021-02-06       Impact factor: 5.531

6.  Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.

Authors:  Christopher A Natale; Jinyang Li; Junqian Zhang; Ankit Dahal; Tzvete Dentchev; Ben Z Stanger; Todd W Ridky
Journal:  Elife       Date:  2018-01-16       Impact factor: 8.140

Review 7.  Melanoma in pregnancy: certainties unborn.

Authors:  Enrico Zelin; Claudio Conforti; Roberta Giuffrida; Teresa Deinlein; Nicola di Meo; Iris Zalaudek
Journal:  Melanoma Manag       Date:  2020-07-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.